Shenzhen Sangel Venture Capital
Overview
Sangel Capital is one of the earliest established healthcare venture capital firms in China. Dedicated to novel technologies and healthcare innovation, the firm focuses on investing in startups in biotech, biopharma, medical devices, and digital health . Sangel Capital provides venture capital and business finance to support high-tech enterprises in China and Western countries .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Genecast | Oct 2020 | Corporate Funding | Co-investor |
| Rongzhi Biotechnology | Nov 2014 | Angel | Co-investor |
| Guangzhou Magpie Pharmaceuticals Co., Ltd. | Feb 2019 | Series B | Lead |
| BriSTAR Immunotech | Oct 2021 | Series B | Co-investor |
| Quantapore, Inc. | Jul 2018 | Series 3 | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Shenzhen Sangel Venture Capital based?
Shenzhen Sangel Venture Capital is headquartered in Shenzhen, Guangdong, China.
When was Shenzhen Sangel Venture Capital founded?
Shenzhen Sangel Venture Capital was founded in 2009.
How many portfolio companies does Shenzhen Sangel Venture Capital have?
Shenzhen Sangel Venture Capital has 14 portfolio companies in Caplight's dataset.
What are some companies in Shenzhen Sangel Venture Capital's portfolio?
Portfolio companies visible on Caplight include Genecast, Rongzhi Biotechnology, Guangzhou Magpie Pharmaceuticals Co., Ltd., BriSTAR Immunotech, Quantapore, Inc..
What was Shenzhen Sangel Venture Capital's most recent investment shown here?
Shenzhen Sangel Venture Capital's most recent investment in this portfolio sample was in BriSTAR Immunotech in 2021.
What sectors does Shenzhen Sangel Venture Capital focus on?
Shenzhen Sangel Venture Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Shenzhen Sangel Venture Capital focus on?
Shenzhen Sangel Venture Capital typically invests at the Mid stage.
What is Shenzhen Sangel Venture Capital's AUM?
Shenzhen Sangel Venture Capital's assets under management are estimated between $100.0M and $250.0M.